Prognostic Relevance of Cytochrome c Oxidase in Primary Glioblastoma Multiforme

Patients with primary glioblastoma multiforme (GBM) have one of the lowest overall survival rates among cancer patients, and reliable biomarkers are necessary to predict patient outcome. Cytochrome c oxidase (CcO) promotes the switch from glycolytic to OXPHOS metabolism, and increased CcO activity i...

Descripción completa

Detalles Bibliográficos
Autores principales: Griguer, Corinne E., Cantor, Alan B., Fathallah-Shaykh, Hassan M., Gillespie, G. Yancey, Gordon, Amber S., Markert, James M., Radovanovic, Ivan, Clement-Schatlo, Virginie, Shannon, Chevis N., Oliva, Claudia R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622606/
https://www.ncbi.nlm.nih.gov/pubmed/23593382
http://dx.doi.org/10.1371/journal.pone.0061035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622606/
https://www.ncbi.nlm.nih.gov/pubmed/23593382
http://dx.doi.org/10.1371/journal.pone.0061035

Ejemplares similares